Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,706 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The basic concepts of molecular modeling.
Saxena A, Wong D, Diraviyam K, Sept D. Saxena A, et al. Methods Enzymol. 2009;467:307-334. doi: 10.1016/S0076-6879(09)67012-9. Methods Enzymol. 2009. PMID: 19897098
Decision-making under risk and its correlates in schizophrenia.
Dong X, Shovestul B, Saxena A, Dudek E, Reda S, Lamberti JS, Dodell-Feder D. Dong X, et al. Among authors: saxena a. Schizophr Res Cogn. 2024 May 9;37:100314. doi: 10.1016/j.scog.2024.100314. eCollection 2024 Sep. Schizophr Res Cogn. 2024. PMID: 38764743 Free PMC article.
Unveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR-T therapies in autoimmunity.
Bodansky A, Yu DJ, Rallistan AN, Kalaycioglu M, Boonyaratanakornkit J, Green DJ, Gauthier J, Turtle CJ, Zorn KC, O'Donovan B, Mandel-Brehm C, Asaki J, Kortbawi H, Kung AF, Rackaityte E, Wang CY, Saxena A, de Dios K, Masi G, Nowak RJ, O'Connor KC, Li H, Diaz VE, Saloner R, Casaletto KB, Gontrum EQ, Chan BJ, Kramer JH, Wilson MR, Utz PJ, Hill JA, Jackson SW, Anderson MS, DeRisi JL. Bodansky A, et al. Among authors: saxena a. J Clin Invest. 2024 May 16:e180012. doi: 10.1172/JCI180012. Online ahead of print. J Clin Invest. 2024. PMID: 38753445 Free article.
Once-daily oral small-molecule glucagon-like peptide-1 receptor agonist lotiglipron (PF-07081532) for type 2 diabetes and obesity: Two randomized, placebo-controlled, multiple-ascending-dose Phase 1 studies.
Buckeridge C, Tsamandouras N, Carvajal-Gonzalez S, Brown LS, Hernandez-Illas M, Saxena AR. Buckeridge C, et al. Among authors: saxena ar. Diabetes Obes Metab. 2024 May 16. doi: 10.1111/dom.15643. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38751362
3,706 results